* Vicarious Surgical Inc RBOT.N reported a quarterly
adjusted
loss of 10 cents per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -21 cents. The mean expectation of
four analysts for the quarter was for a loss of 9 cents per
share. Wall Street expected results to range from -12 cents
to -8 cents per share.
* Reported revenue was zero; analysts expected zero.
* Vicarious Surgical Inc's reported EPS for the quarter was
a loss
of 10 cents.
* The company reported a quarterly loss of $17 million.
* Vicarious Surgical Inc shares had fallen by 10.4% this
quarter and lost 26.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 16.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Vicarious
Surgical Inc is $1.00
This summary was machine generated from LSEG data April 30 at
02:04 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.09 -0.10 Missed
Dec. 31 2023 -0.12 -0.06 Beat
Sep. 30 2023 -0.14 -0.10 Beat
Jun. 30 2023 -0.14 -0.12 Beat